"The recreational use of nitrous oxide, often perceived as harmless, can lead to a potentially dangerous condition where air escapes into the chest cavity, mimicking more severe medical emergencies and highlighting the need for increased awareness and regulatory action."
A concerning case emerging from the United Kingdom underscores the often-underestimated risks associated with nitrous oxide, commonly known as "laughing gas." An 18-year-old male presented to a British emergency department with severe chest pain, later diagnosed with pneumomediastinum—a condition where air accumulates in the mediastinum, the central compartment of the thoracic cavity. This incident, detailed in the Journal of Medical Case Reports, occurred after the individual inhaled multiple balloons of nitrous oxide, underscoring a growing public health concern that is prompting legislative action in the United States. While this particular injury is rare, the increasing popularity of nitrous oxide, coupled with its potential for serious adverse effects, necessitates a comprehensive understanding of its dangers.
The 18-year-old’s ordeal began with a sharp, central chest pain that radiated upwards into his throat, a discomfort that intensified when he reclined. Subsequent diagnostic imaging, specifically a CT scan, revealed a significant escape of air that had not only entered the mediastinum but also spread extensively into surrounding anatomical regions. The air tracked upwards into his neck, outwards towards his armpits (axillary regions), anterior to his breastbone (presternal region), and along the frontal aspect of the pericardium, the protective sac encasing the heart. This widespread distribution of air, while visually striking, did not involve air within the pericardial sac itself, which would constitute a more critical complication known as pneumopericardium.
Before the full extent of the air accumulation was visualized, medical professionals detected physical evidence of subcutaneous emphysema—a palpable crackling sensation beneath the skin, particularly in the neck. This finding, also visible on a chest X-ray, served as an early indicator of trapped air. Despite the alarming radiological findings, the patient was hemodynamically stable, alert, conversing normally, and maintaining adequate oxygen saturation. His cardiac markers were also within normal limits, initially ruling out acute cardiac injury.
The diagnostic process prioritized ruling out more immediate life-threatening conditions, chief among them a perforated esophagus. A tear in the esophagus, the muscular tube connecting the pharynx to the stomach, can lead to the leakage of air and gastric contents into the mediastinum, a scenario requiring urgent surgical intervention. To address this concern, a water-soluble contrast study was performed. This procedure involves the patient swallowing a contrast agent that, if there were a tear, would leak out and be visible on imaging. The study, however, revealed no esophageal perforation, thereby shifting the diagnostic focus towards the patient’s reported recreational drug use.
The leading hypothesis for the pneumomediastinum pointed towards the inhalation of nitrous oxide. Medical literature suggests several mechanisms by which this can occur. The "Macklin effect" is a prominent theory, proposing that forceful breath-holding, often associated with the inhalation of substances like nitrous oxide, can increase intrathoracic pressure. This elevated pressure can cause small air sacs (alveoli) at the terminal ends of the airways to rupture, allowing air to dissect along the bronchovascular sheaths into the mediastinum. An alternative proposed mechanism involves the direct toxic effects of the gas, potentially leading to vasoconstriction and subsequent tissue damage that facilitates air leakage.
Adding a layer of complexity to the case, the young man also disclosed the use of cocaine and ecstasy. Inhaled recreational drugs, including crack cocaine, are recognized causes of pneumomediastinum. While the published case report primarily focused on nitrous oxide as the likely culprit, it acknowledged that the concurrent use of other substances could have contributed to the event. A single case report is insufficient to definitively attribute the pneumomediastinum to a specific drug or combination, underscoring the challenge of isolating etiological factors in poly-substance use.
The patient’s clinical course remained stable during his hospital admission, but the outcome was ultimately unresolved. He opted to leave against medical advice before further diagnostic evaluations were completed and was subsequently lost to follow-up. Generally, the body can reabsorb leaked air from the mediastinum over time, but potential complications, such as a tension pneumothorax (a life-threatening condition where air accumulates in the pleural space, collapsing the lung), remain a concern.
The authors of the report emphasized that this particular complication—pneumomediastinum—is an uncommon sequela of nitrous oxide use. Their review of existing literature revealed only a limited number of case reports or series documenting similar occurrences, indicating that this is not a typical outcome of laughing gas consumption. However, the widespread availability and popularity of nitrous oxide, particularly among young adults, amplify the significance of even rare adverse events. Data from England and Wales indicated that nitrous oxide was the second most prevalent recreational drug among young adults in 2019. In recognition of its growing misuse and associated harms, the United Kingdom classified nitrous oxide as a Class C controlled drug in November 2023, making its recreational possession illegal.
The primary takeaway for healthcare professionals from this case is the critical importance of inquiring about illicit drug use when obtaining a patient’s medical history, especially in cases presenting with unexplained chest pain. The drug history in this instance only came to light after imaging, potentially delaying the diagnostic process. Early identification of recreational substance use can significantly aid in guiding appropriate management and treatment strategies.
In the United States, regulatory bodies and state governments are increasingly taking action against the sale and use of nitrous oxide, particularly in its common retail form as small, flavored canisters. In March 2025, the U.S. Food and Drug Administration (FDA) issued a consumer warning advising against inhaling these products, a warning updated in June 2025 to specifically name over a dozen brands. The FDA highlighted a range of serious health risks associated with inhaling nitrous oxide, including vitamin B12 deficiency, which can lead to neurological damage and paralysis, loss of consciousness, psychiatric disturbances, asphyxiation, and, in severe cases, death.
The public health threat posed by nitrous oxide is underscored by a dramatic increase in related fatalities. A research letter published in JAMA Network Open in July 2025, utilizing Centers for Disease Control and Prevention (CDC) mortality data, reported that nitrous oxide-related deaths in the U.S. surged from 23 in 2010 to 156 in 2023—a staggering 578% relative increase. Experts describe the gas as "deceptively safe," a perception that likely contributes to its widespread misuse.
In response to these alarming trends, several U.S. states have enacted legislation to curb the retail availability of nitrous oxide. Tennessee implemented a ban on retail sales effective July 1, 2026. More recently, Florida enacted "Meg’s Law," named in memory of Meg Caldwell, a 29-year-old who died in 2024 after purchasing nitrous oxide from a smoke shop. This law, effective October 1, 2026, makes it a third-degree felony for tobacco and nicotine retailers, including smoke shops, to sell the gas.
The case of the 18-year-old in the UK adds a lesser-known, yet potentially serious, injury to the growing list of adverse effects associated with nitrous oxide. The presentation of sudden chest pain radiating to the neck, particularly when accompanied by palpable subcutaneous emphysema, should prompt immediate emergency medical evaluation. Open communication with healthcare providers regarding all substances inhaled is paramount for ensuring accurate and timely diagnosis and effective management of potentially life-threatening conditions.
Key Questions Answered
What happened to the 18-year-old?
The 18-year-old developed pneumomediastinum, characterized by air accumulation in the central chest cavity between the lungs and around the heart. This condition arose after he inhaled five balloons of nitrous oxide. A CT scan further revealed that the air had spread into his neck, towards his armpits, and anterior to his breastbone.
Was the air inside the sac around his heart?
No. The CT scan indicated that the air was present along the front of the pericardium, the sac that surrounds the heart. However, the report did not describe air accumulating inside the pericardial sac itself, which would be a distinct and more critical condition known as pneumopericardium.
Did laughing gas definitely cause it?
While doctors ruled out a torn esophagus, a more immediately life-threatening cause of pneumomediastinum, the definitive cause remains somewhat uncertain. The medical team attributed the air leak primarily to nitrous oxide inhalation. However, the patient had also used cocaine and ecstasy, and inhaled drugs such as crack cocaine are known to cause pneumomediastinum. Therefore, it is difficult to definitively state whether nitrous oxide alone, or a combination of substances, was responsible.
Is this a common side effect of nitrous oxide?
No, pneumomediastinum is considered an uncommon side effect of nitrous oxide. The authors of the case report found only a handful of similar cases documented in medical literature. The more widely publicized harms associated with nitrous oxide, as highlighted by the FDA, include vitamin B12 deficiency, paralysis, and loss of consciousness.
What are U.S. states doing about nitrous oxide?
Several U.S. states are taking legislative action to restrict the sale of nitrous oxide. Tennessee prohibited retail sales as of July 1, 2026. Florida’s "Meg’s Law," which went into effect on October 1, 2026, prohibits tobacco and nicotine retailers, such as smoke shops, from selling nitrous oxide, classifying violations as a third-degree felony.
